Premium Nahrungsergänzungsmittel | artgerecht

Interdigitating Dendritic Cell – Function & Role

Interdigitating dendritic cells are specialised immune cells located in the T-cell zones of lymphoid organs. They present antigens and activate naive T-lymphocytes.

Regular tips about health Regular tips about health

Things worth knowing about "Interdigitating dendritic cell"

Interdigitating dendritic cells are specialised immune cells located in the T-cell zones of lymphoid organs. They present antigens and activate naive T-lymphocytes.

What is an interdigitating dendritic cell?

The interdigitating dendritic cell (IDC) is a highly specialised subtype of dendritic cells of the immune system. It belongs to the group of antigen-presenting cells (APCs) and is found predominantly in the T-cell zones of secondary lymphoid organs, including the paracortex of lymph nodes, the spleen, and the Peyer patches of the intestine. Its name derives from the characteristic finger-like cytoplasmic extensions with which it makes close contact with neighbouring T-lymphocytes – a process known as interdigitation.

Origin and differentiation

Interdigitating dendritic cells originate from haematopoietic progenitor cells in the bone marrow. They are derived through the myeloid lineage from monocytic or dendritic precursors and travel via the blood and lymphatics to peripheral tissues. There, as immature dendritic cells, they capture antigens. Following antigen uptake, they mature, lose their phagocytic capacity, and migrate to regional lymph nodes, where they function as interdigitating dendritic cells.

Function and mechanism of action

The primary role of interdigitating dendritic cells is the activation of naive T-lymphocytes. This process involves several key steps:

Antigen uptake: In peripheral tissues, immature dendritic cells capture antigens via phagocytosis, macropinocytosis, or receptor-mediated endocytosis.
Antigen processing: Internalized proteins are cleaved into short peptide fragments within intracellular compartments.
Antigen presentation: Peptides are loaded onto MHC class II molecules (for CD4+ T cells) or MHC class I molecules (for CD8+ T cells) and displayed on the cell surface.
T-cell activation: Interaction between the MHC-peptide complex and the T-cell receptor (TCR) provides the first activation signal. Co-stimulatory molecules such as CD80 and CD86 (B7 family) and the release of cytokines (e.g., IL-12) supply the essential second signal required for full T-cell activation.

Interdigitating dendritic cells are considered the most potent antigen-presenting cells for initiating adaptive immune responses and are critical for distinguishing self from non-self.

Importance for the immune system

Through their capacity to activate naive T cells, interdigitating dendritic cells play a key role in initiating adaptive immune responses. They are centrally involved in defence against pathogens, tumour immunity, and the establishment of tolerance to self-antigens. Dysfunction of these cells can contribute to the development of autoimmune diseases or impaired immune defence.

Clinical relevance

Interdigitating dendritic cells are the subject of intensive research in the fields of immunotherapy and vaccine development. Dendritic cell-based therapies, in which a patient's own dendritic cells are loaded with tumour antigens and reinfused, exploit the activation potential of these cells to specifically induce anti-tumour T-cell responses. Furthermore, altered IDC function has been described in various immunopathological conditions including HIV infection, rheumatoid arthritis, and certain lymphomas.

Distinction from related cell types

Dendritic cells comprise several functionally distinct subtypes:

Interdigitating dendritic cells: T-cell zones; activation of naive T-lymphocytes
Follicular dendritic cells (FDC): B-cell follicles; antigen presentation to B-lymphocytes (non-haematopoietic origin)
Langerhans cells: Skin epidermis; local immune defence
Plasmacytoid dendritic cells (pDC): Production of large quantities of type I interferons during viral infections

References

Steinman, R. M. (2007). Dendritic cells: Understanding immunogenicity. European Journal of Immunology, 37(S1), S53–S60.
Banchereau, J. & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature, 392(6673), 245–252.
Janeway, C. A. et al. (2001). Immunobiology: The Immune System in Health and Disease. 5th edition. Garland Science, New York.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.